{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:39:11Z","timestamp":1795059551354,"version":"4.10.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13104-015-1594-x","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T14:36:15Z","timestamp":1446129375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Prevalence and factors associated with VIA positive result among clients screened at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, Ethiopia 2013: a cross-sectional study"],"prefix":"10.1186","volume":"8","author":[{"given":"Zewdie Mulissa","family":"Deksissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fessahaye Alemseged","family":"Tesfamichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henok Assefa","family":"Ferede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,29]]},"reference":[{"key":"1594_CR1","unstructured":"Berek JS, editor. Berek and Novak\u2019s gynecology. 14th ed. Stanford: Lippincott Williams & Wilkins; 2007."},{"key":"1594_CR2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JMJ Walboomers","year":"1999","unstructured":"Walboomers JMJ, Manos MM. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12\u20139.","journal-title":"J Pathol"},{"key":"1594_CR3","unstructured":"WHO. Comprehensive cervical cancer prevention and control: a healthier future for girls and women. Geneva, Switzerland; 2013."},{"key":"1594_CR4","unstructured":"Ferlay JS, Bray F, Forman D, Mathers C. GLOBOCAN 2008: cancer Incidence and Mortality Worldwide in 2008. Lyon, France: International Agency for Research on Cancer. 2010; 2013. Available from: http:\/\/globocan.iarc.f ."},{"key":"1594_CR5","unstructured":"Castellsagu\u00e9 XS, Aguado T, Louie KS, Bruni L, Mu\u00f1oz J, et al. HPV and Cervical Cancer in the World: WHO\/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre); 2007."},{"key":"1594_CR6","unstructured":"Addis Tesfa: May 2011 Project Brief. Pathfinder International; 2011."},{"key":"1594_CR7","unstructured":"Jhpiego. Cervical cancer prevention guidelines for low-resource settings. Baltimore, Maryland; 2005."},{"key":"1594_CR8","unstructured":"Ethiopia demographic and health survey 2011. Addis Ababa, Ethiopia: central statistical agency, Ethiopia, ICF international calverton, Maryland; 2012."},{"key":"1594_CR9","unstructured":"Adnew SS-D, Blumenthal PD, Shiferaw N, Ansel J, Sisay G. Introducing cervical cancer prevention using visual inspection with acetic acid (VIA) and cryotherapy among HIV-positive women: new hope for Ethiopian women. International AIDS conference Washington DC; 2012."},{"issue":"12","key":"1594_CR10","doi-asserted-by":"crossref","first-page":"e84519","DOI":"10.1371\/journal.pone.0084519","volume":"8","author":"A Gedefaw","year":"2013","unstructured":"Gedefaw A, Astatkie\u00a0A, Tesema GA. The prevalence of precancerous cervical cancer lesion among HIV-infected women in Southern Ethiopia: a cross-sectional study. PLoS One. 2013;8(12):e84519.","journal-title":"PLoS One"},{"key":"1594_CR11","unstructured":"WHO. Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy. A demonstration project in six African countries: (Malawi, Madagascar, Nigeria, Uganda, the United Republic of Tanzania, and Zambia). Geneva; 2012."},{"issue":"3","key":"1594_CR12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1258\/0969141054855328","volume":"12","author":"LOD Sarian","year":"2005","unstructured":"Sarian LOD, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol\u2019s iodine (VILI), cervical cytology and HPV testing as cervical screening tools in latin America. J Med Screen. 2005;12(3):142\u20139.","journal-title":"J Med Screen"},{"key":"1594_CR13","first-page":"814","volume":"61","author":"RTCOG\/JHPIEGO","year":"2003","unstructured":"RTCOG\/JHPIEGO. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet. 2003;61:814\u201320.","journal-title":"Lancet"},{"issue":"6","key":"1594_CR14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1440-1584.2008.01013.x","volume":"16","author":"TL Ogunbowale","year":"2008","unstructured":"Ogunbowale TL. Cervical cancer risk factors and predictors of cervical dysplasia among women in south-west Nigeria. Austral J Rural Health. 2008;16(6):338\u201342.","journal-title":"Austral J Rural Health"},{"key":"1594_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/IJWH.S14189","volume":"3","author":"AR Ibrahim","year":"2011","unstructured":"Ibrahim AR, Pukkala E, Aro AR. Cervical cancer risk factors and feasibility of visual inspection with acetic acid screening in Sudan. Int J Womens Health. 2011;3:117\u201322.","journal-title":"Int J Womens Health"},{"key":"1594_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4236\/ojog.2012.22027","volume":"2","author":"LSD Bradford","year":"2012","unstructured":"Bradford LSD, Hussain SMA, Begum SR, Hussain F, Hoque S, et al. Development of a cervical cancer screening program in a slum setting using visual inspection with acetic acid: analysis of feasibility and cost. Open J Obstet Gynecol. 2012;2:140\u20136.","journal-title":"Open J Obstet Gynecol"},{"issue":"5","key":"1594_CR17","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1158\/1055-9965.EPI-09-1282","volume":"19","author":"HS Vedantham","year":"2010","unstructured":"Vedantham HS, Kalpana B, Rekha C, Karuna BP, Vidyadhari K, et al. Determinants of VIA (Visual inspection of the cervix after acetic acid application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India. Cancer Epidemiol Biomark Prev. 2010;19(5):1373\u201380.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"1594_CR18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10552-005-0296-4","volume":"16","author":"CG Mah\u00e9","year":"2005","unstructured":"Mah\u00e9 CG. Screening test accuracy studies: how valid are our conclusions? Application to visual inspection methods for cervical screening. Cancer Causes Control. 2005;16(6):657\u201366.","journal-title":"Cancer Causes Control"},{"issue":"13\u201314","key":"1594_CR19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/15287391003744823","volume":"73","author":"SIK Ferreirada","year":"2010","unstructured":"Ferreirada SIK, Quinto SSC, Ferreirade ANO, Koifman S. TP53 genetic polymorphisms and environmental risk factors associated with cervical carcinogenesis in a cohort of Brazilian women with cervical lesions. Toxicol Environtal Health. 2010;73(13\u201314):888\u2013900.","journal-title":"Toxicol Environtal Health"},{"issue":"3","key":"1594_CR20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ije\/26.3.491","volume":"26","author":"LNM Biswas","year":"1997","unstructured":"Biswas LNM, Maiti PK, engupta S. Sexual risk factors for cervical cancer among rural Indian women: a case\u2013control study. Int J Epidemiol. 1997;26(3):491\u20135.","journal-title":"Int J Epidemiol"},{"key":"1594_CR21","unstructured":"WHO. Comprehensive cervical cancer control: a guide to essential practice. Geneva; 2006."},{"issue":"2","key":"1594_CR22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0020-7292(99)00043-0","volume":"65","author":"MT Temmerman","year":"1999","unstructured":"Temmerman MT, Kidula N, Claeys P, Muchiri L, Quint W. Risk factors for human papilloma virus and cervical precancerous lesions, and the role of concurrent HIV-1 infection. Int J Gynaecol Obstet. 1999;65(2):171\u201381.","journal-title":"Int J Gynaecol Obstet"},{"key":"1594_CR23","doi-asserted-by":"crossref","unstructured":"Memiah PM, Kiiru G, Agbor S, Odhiambo F, Ojoo S et al. Prevalence and risk factors associated with precancerous cervical cancer lesions among HIV-infected women in resource-limited settings. AIDS Res Treat. 2012.","DOI":"10.1155\/2012\/953743"},{"key":"1594_CR24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1186\/1471-2458-12-1055","volume":"12","author":"CK Kahesa","year":"2012","unstructured":"Kahesa CK, Ngoma T, Mwaisejage J, Dartell M, Iftner T, et al. Risk factors for VIA positivity and determinants of screening attendances in Dar es Salaam, Tanzania. BMC Public Health. 2012;12:1055.","journal-title":"BMC Public Health"},{"issue":"1","key":"1594_CR25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1055-9965.EPI-03-0191","volume":"13","author":"Ho","year":"2004","unstructured":"Ho, G YFS, Bierman R, Burk RD. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomark Prev. 2004;13(1):110\u20136.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"1594_CR26","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/IGC.0b013e3182288104","volume":"21","author":"AC Maribel","year":"2011","unstructured":"Maribel AC, Miguel G, Manuel DJ, Hilary BC, Silvana L, et al. Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in Peru. Int J Gynecol Cancer. 2011;21(9):1654\u201363.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"1594_CR27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-9378-6-16","volume":"6","author":"SMB Mbulaiteye","year":"2011","unstructured":"Mbulaiteye SMB, Adebamowo C, Sasco AJ. HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infect Agent Cancer. 2011;6(1):16\u20138.","journal-title":"Infect Agent Cancer"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1594-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T22:28:56Z","timestamp":1498256936000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1756-0500\/8\/618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1594"],"URL":"https:\/\/doi.org\/10.1186\/s13104-015-1594-x","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]},"article-number":"618"}}